Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$32M Sell
110,400
-700
-0.6% -$197K 0.14% 120
2018
Q1
$30.4M Buy
111,100
+85,700
+337% +$26.6M 0.13% 128
2017
Q4
$8.09M Sell
25,400
-5,900
-19% -$1.89M 0.04% 567
2017
Q3
$9.8M Sell
31,300
-33,700
-52% -$9.98M 0.05% 426
2017
Q2
$17.6M Buy
65,000
+11,500
+21% +$3.04M 0.1% 190
2017
Q1
$14.6M Sell
53,500
-133,700
-71% -$37.8M 0.12% 184
2016
Q4
$53.1M Sell
187,200
-43,400
-19% -$12.9M 0.38% 17
2016
Q3
$72.2M Buy
230,600
+42,600
+23% +$12.6M 0.54% 8
2016
Q2
$45.5M Buy
188,000
+89,500
+91% +$23.6M 0.35% 21
2016
Q1
$25.6M Sell
98,500
-24,000
-20% -$6.34M 0.21% 82
2015
Q4
$37.5M Sell
122,500
-92,600
-43% -$26.6M 0.25% 44
2015
Q3
$62.8M Buy
215,100
+153,100
+247% +$50.6M 0.33% 18
2015
Q2
$25M Sell
62,000
-600
-1% -$241K 0.15% 128
2015
Q1
$26.4M Sell
62,600
-55,200
-47% -$21.8M 0.2% 73
2014
Q4
$40M Buy
117,800
+6,700
+6% +$2.17M 0.3% 25
2014
Q3
$36.8M Buy
111,100
+67,500
+155% +$22.3M 0.28% 41
2014
Q2
$13.7M Buy
43,600
+6,000
+16% +$1.81M 0.13% 165
2014
Q1
$11.5M Buy
37,600
+30,300
+415% +$9.62M 0.1% 228
2013
Q4
$2.04M Sell
7,300
-27,900
-79% -$7.22M 0.01% 1441
2013
Q3
$4.24M Buy
35,200
+13,100
+59% +$2.93M 0.03% 893
2013
Q2
$4.76K Buy
+22,100
New +$4.72M 0.02% 792

Other funds holding BIIB

PEAK6 Group's BIIB Position: Q2 2018 in Review

PEAK6 Group sold out of Biogen (BIIB) in Q2 2018, closing a stake of 24,081 shares — an estimated $6.77M sold.

PEAK6 Group first reported a position in BIIB in Q2 2013 and held it in 17 quarters. The position peaked at $34M in Q4 2014. 1,097 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • PEAK6 Group reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 24,081 Biogen shares in Q2 2018, an estimated $6.77M.
  • PEAK6 Group first reported a position in Biogen in Q2 2013 and held it in 17 quarters.
  • PEAK6 Group's Biogen position peaked at $34M in Q4 2014.
  • 1,097 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.